NCT00087503 - Intravenous Edotecarin in Patients With Advanced Gastric Cancer That Has Progressed or Recurred After Chemotherapy | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 30, 2004

Primary Completion Date

June 30, 2005

Study Completion Date

June 30, 2005

Conditions

Stomach Neoplasms

Interventions

DRUG

Edotecarin

Trial Locations (10)

Pfizer Investigational Site, Brussels

Pfizer Investigational Site, Ghent

Pfizer Investigational Site, Leuven

Pfizer Investigational Site, Lille

Pfizer Investigational Site, Barcelona

Pfizer Investigational Site, Madrid

Pfizer Investigational Site, Kaohsiung City

Pfizer Investigational Site, Kwei-Shan

Pfizer Investigational Site, Birmingham

Pfizer Investigational Site